g3pharma.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	Home - G3
Description	We are Just Starting but Have Come a Long Home About Galectin-3 Validated Target Galectin-3 Dependent Conditions Our Strategy and Plan About Us Founders Contact Investor Interest Media Home About
Keywords	N/A

Server Information

WebSite	g3pharma.com
Host IP	66.96.147.106
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

g3pharma.com Valuation

US$1,592

Last updated: 2023-05-17 23:14:12

g3pharma.com has Semrush global rank of 0. g3pharma.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. g3pharma.com receives approximately 183 unique visitors each day. Its web server is located in United States, with IP address 66.96.147.106. According to SiteAdvisor, g3pharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,592
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$44
Yearly Ads Revenue	US$529
Daily Unique Visitors	12
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
g3pharma.com.	A	3596	IP: 66.96.147.106
g3pharma.com.	NS	3600	NS Record: ns1.ipage.com.
g3pharma.com.	NS	3600	NS Record: ns2.ipage.com.
g3pharma.com.	MX	3600	MX Record: 30 mx.g3pharma.com.
g3pharma.com.	MX	3600	MX Record: 0 g3pharma-com.mail.protection.outlook.com.
g3pharma.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
g3pharma.com.	TXT	3600	TXT Record: MS=ms71218252

HtmlToTextCheckTime:2023-05-17 23:14:12

Home About Galectin-3 Validated Target Galectin-3 Dependent Conditions Our Strategy and Plan About Us Founders Contact Investor Interest Media Home About Galectin-3 Validated Target Galectin-3 Dependent Conditions Our Strategy and Plan About Us Founders Contact Investor Interest Media Leading the way. G-3 in our name stands for Galectin 3 A remarkable and important protein. Everyday a new paper is published about Galectin-3. Countless papers characterize Galectin-3 as a promising target. Our studies have validated it as a druggable target for cardiovascular and renal disease. Lead optimization is our next step toward the clinic. READ RECENT NEWS The work we started 10 years ago sparked scientific interest in galectin-3 around the world. The insights it produced form the foundation of our company. Galectin-3 Primer Galectin-3 ..is a protein that regulates functions of other cells ..has a built-in “on-off” switch controlled by special carbohydrates ..promotes fibrosis in response to

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Apr 2022 08:22:02 GMT
Content-Type: text/html; charset=iso-8859-1
Content-Length: 229
Connection: keep-alive
Server: Apache/2
Location: https://g3pharma.com/
Cache-Control: max-age=3600
Expires: Wed, 27 Apr 2022 08:41:16 GMT
Age: 2446

HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Apr 2022 08:22:03 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Server: Apache/2
X-Powered-By: PHP/7.2.15
Location: https://www.g3pharma.com/
Age: 1

HTTP/1.1 200 OK
Date: Wed, 27 Apr 2022 08:22:04 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Server: Apache/2
X-Powered-By: PHP/7.2.15
Link: ; rel="https://api.w.org/"
Link: ; rel=shortlink
Age: 2

g3pharma.com Whois Information

Domain Name: G3PHARMA.COM
Registry Domain ID: 2143967218_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domain.com
Registrar URL: http://www.domain.com
Updated Date: 2021-07-02T12:58:13Z
Creation Date: 2017-07-17T12:08:16Z
Registry Expiry Date: 2022-07-17T12:08:16Z
Registrar: Domain.com, LLC
Registrar IANA ID: 886
Registrar Abuse Contact Email: compliance@domain-inc.net
Registrar Abuse Contact Phone: 602-226-2389
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.IPAGE.COM
Name Server: NS2.IPAGE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-04-27T09:01:33Z <<<

g3pharma.com valuation and analysis